Membership : Our Members
Angiogenesis Foundation
Founded in 1994, the Angiogenesis Foundation is the world's first nonprofit organization dedicated to conquering disease using a new approach based on angiogenesis, the process by which humans and animals grow blood vessels in the body.
Therapeutic angiogenesis modalities represent a broad range of interventions that generate new blood vessel growth to promote neovascularization and tissue repair. Presently, there are three major indications for which angiogenic therapies are in clinical use or development: 1) peripheral arterial disease; 2) ischemic heart disease; and 3) chronic wounds (e.g. diabetic lower extremity ulcers, venous leg ulcerations, pressure ulcers, arterial ulcers). In such conditions, the therapeutic goal is to stimulate angiogenesis to improve perfusion, deliver growth factors to sites of tissue repair, mobilize regenerative stem cell populations, and ultimately, restore form and function to the tissue.
The goals of the Foundation are: 1) to advance modern medicine by championing a new approach to health and disease; 2) to improve the lives of people who can benefit from angiogenesis treatments and preventative measures on a global scale; 3) to transform the way society views health and disease based on the balance of angiogenesis in the body.
We are committed to helping people around the world benefit from the full promise of this approach, and to make the treatments available to everyone in need.
The Angiogenesis Foundation is creating an online global community to participate in this new approach for conquering disease: join us here.
To learn more, visit The Angiogenesis Foundation
Founded in 1994, the Angiogenesis Foundation is the world's first nonprofit organization dedicated to conquering disease using a new approach based on angiogenesis, the process by which humans and animals grow blood vessels in the body.
Therapeutic angiogenesis modalities represent a broad range of interventions that generate new blood vessel growth to promote neovascularization and tissue repair. Presently, there are three major indications for which angiogenic therapies are in clinical use or development: 1) peripheral arterial disease; 2) ischemic heart disease; and 3) chronic wounds (e.g. diabetic lower extremity ulcers, venous leg ulcerations, pressure ulcers, arterial ulcers). In such conditions, the therapeutic goal is to stimulate angiogenesis to improve perfusion, deliver growth factors to sites of tissue repair, mobilize regenerative stem cell populations, and ultimately, restore form and function to the tissue.
The goals of the Foundation are: 1) to advance modern medicine by championing a new approach to health and disease; 2) to improve the lives of people who can benefit from angiogenesis treatments and preventative measures on a global scale; 3) to transform the way society views health and disease based on the balance of angiogenesis in the body.
We are committed to helping people around the world benefit from the full promise of this approach, and to make the treatments available to everyone in need.
The Angiogenesis Foundation is creating an online global community to participate in this new approach for conquering disease: join us here.
To learn more, visit The Angiogenesis Foundation
